Active Pharmaceutical Ingredient (API)
Daclatasvir Dihydrochloride
Antiviral (Hepatitis C - $\text{NS5A}$ Inhibitor)
A highly selective inhibitor of the $\text{HCV}$ $\text{NS5A}$ protein, essential for viral RNA replication and virion assembly. It is used in combination with Sofosbuvir (or similar agents) for the treatment of chronic $\text{HCV}$ infection, forming a dual-acting regimen with high pangenotypic efficacy.
Technical Profile
- Reference Code
- DAC302
- CAS Number
- 1009119-65-8
- Molecular Weight
- 738.90 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C40H50N8O6·2HCl
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Daclatasvir Dihydrochloride as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||